Drug profile · INN
daunorubicin + cytarabine
VYXEOS
daunorubicin + cytarabine (VYXEOS) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — daunorubicin + cytarabine
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 4
- Data quality
- 0.81
Quick answer
daunorubicin + cytarabine (VYXEOS) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is daunorubicin + cytarabine?
daunorubicin + cytarabine (VYXEOS) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for daunorubicin + cytarabine?
VYXEOS is a marketed brand name for daunorubicin + cytarabine. Check FDA Drugs@FDA for the current US label holder and prescribing information.